STN: 103935
Proper Name: Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
Tradename: ActHIB
Manufacturer: Sanofi Pasteur, SA
Indication:

• ActHIB vaccine is indicated for the active immunization of infants and children 2 months through 5 years of age for the prevention of invasive disease caused by H influenzae type b.

Product Information

• Package Insert - ActHIB

Supporting Documents

• May 24, 2019 Approval Letter - ActHIB
• December 20, 2018 Approval Letter - ActHIB
• Supporting Documents older than three years - ActHIB